IL10 and inflammatory bowel disease: IL‐10 production by ManLAM‐treated B cells is predominantly mediated TLR2‐signalling pathway.16 We hypothesize that ManLAM might be recognized by other receptors on B cells and employ other mechanism to ameliorate IBD.